Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fokas

Showing results (281-290 of 329) with videos related to

Pageof 33
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2018
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trialE Fokas, R Fietkau, A Hartmann, et al.
Cell Reports|December 28, 2017
Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal CancerKevin Tong, Oscar Pellón-Cárdenas, Veerin R Sirihorachai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2016
ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancerJames M Wilson, Emmanouil Fokas, Susan J Dutton, et al.
Scientific Reports|February 13, 2025
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trialJochen Gaedcke, Malte Sahrhage, Marcel Ebeling, et al.
Journal of Clinical Psychology|May 3, 2023
Clinical determinants of involuntary psychiatric hospitalization: A clinical profile approachEugenie Georgaca, Sofia Machaira, Dimitrios Stamovlasis, et al.
Nature Communications|July 26, 2016
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxiaThomas M Ashton, Emmanouil Fokas, Leoni A Kunz-Schughart, et al.
Clinical and Translational Radiation Oncology|March 5, 2026
ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancerGiuditta Chiloiro, Angela Romano, Regina Beets-Tan, et al.
Mayo Clinic Proceedings|February 7, 2021
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled TrialsDario Pasalic, C David Fuller, Walker Mainwaring, et al.
Clinical and Translational Radiation Oncology|July 1, 2026
Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centeredKrishan R Jethwa, J Joshua Smith, Hanna Sanoff, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2020
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trialRebekka Kosmala, Emmanouil Fokas, Michael Flentje, et al.
Pageof 33

Showing results (281-290 of 329) with videos related to

Sort By:
Pageof 33
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2018
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trialE Fokas, R Fietkau, A Hartmann, et al.
Cell Reports|December 28, 2017
Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal CancerKevin Tong, Oscar Pellón-Cárdenas, Veerin R Sirihorachai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2016
ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancerJames M Wilson, Emmanouil Fokas, Susan J Dutton, et al.
Scientific Reports|February 13, 2025
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trialJochen Gaedcke, Malte Sahrhage, Marcel Ebeling, et al.
Journal of Clinical Psychology|May 3, 2023
Clinical determinants of involuntary psychiatric hospitalization: A clinical profile approachEugenie Georgaca, Sofia Machaira, Dimitrios Stamovlasis, et al.
Nature Communications|July 26, 2016
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxiaThomas M Ashton, Emmanouil Fokas, Leoni A Kunz-Schughart, et al.
Clinical and Translational Radiation Oncology|March 5, 2026
ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancerGiuditta Chiloiro, Angela Romano, Regina Beets-Tan, et al.
Mayo Clinic Proceedings|February 7, 2021
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled TrialsDario Pasalic, C David Fuller, Walker Mainwaring, et al.
Clinical and Translational Radiation Oncology|July 1, 2026
Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centeredKrishan R Jethwa, J Joshua Smith, Hanna Sanoff, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2020
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trialRebekka Kosmala, Emmanouil Fokas, Michael Flentje, et al.
Pageof 33